MEPROBAMATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Meprobamate, and what generic alternatives are available?
Meprobamate is a drug marketed by Acella, Alembic Pharms Ltd, Barr, Chartwell Molecular, Elkins Sinn, Heather, Impax Labs, Invagen Pharms, Ivax Sub Teva Pharms, Lederle, Lee Km, Mallard, Mk Labs, Mylan, Nexgen Pharma Inc, Parke Davis, Perrigo, Pharmavite, Purepac Pharm, Pvt Form, Rising, Roxane, Sandoz, Scherer Labs, Solvay, Stanlabs Pharm, Sun Pharm Industries, Tablicaps, Taro, Usl Pharma, Valeant Pharm Intl, Vangard, Watson Labs, West Ward, Whiteworth Town Plsn, and Par Pharm. and is included in forty-seven NDAs.
The generic ingredient in MEPROBAMATE is aspirin; meprobamate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; meprobamate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MEPROBAMATE?
- What are the global sales for MEPROBAMATE?
- What is Average Wholesale Price for MEPROBAMATE?
Summary for MEPROBAMATE
| US Patents: | 0 |
| Applicants: | 36 |
| NDAs: | 47 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 41 |
| Patent Applications: | 3,876 |
| Drug Prices: | Drug price information for MEPROBAMATE |
| DailyMed Link: | MEPROBAMATE at DailyMed |
Medical Subject Heading (MeSH) Categories for MEPROBAMATE
Anatomical Therapeutic Chemical (ATC) Classes for MEPROBAMATE
US Patents and Regulatory Information for MEPROBAMATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stanlabs Pharm | MEPROBAMATE | meprobamate | TABLET;ORAL | 014474-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Purepac Pharm | MEPROBAMATE | meprobamate | TABLET;ORAL | 084804-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Valeant Pharm Intl | MEPROBAMATE | meprobamate | TABLET;ORAL | 015139-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Whiteworth Town Plsn | MEPROBAMATE | meprobamate | TABLET;ORAL | 083830-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Taro | MEPROBAMATE | meprobamate | TABLET;ORAL | 200998-001 | May 23, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Valeant Pharm Intl | MEPROBAMATE | meprobamate | TABLET;ORAL | 015139-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | MEPROBAMATE | meprobamate | TABLET;ORAL | 085721-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
